XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.2
Equity Incentive Plans (Tables)
3 Months Ended
Jul. 31, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Restricted Units Activity

 

Predecessor            
  

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
             
Outstanding, April 30, 2025   -   $-   $- 
Granted   -   $-   $- 
Vested and settled with share issuance   -   $-   $- 
Forfeited/cancelled   -   $-   $- 
Outstanding, June 6, 2025   -   $-   $- 

 

Successor            
  

Number of

Units

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

 
             
Outstanding, June 7, 2025   1,529   $8.18   $41,314 
Granted   524,999   $8.88   $14,185,473 
Vested and settled with share issuance   (1,529)  $8.18   $(41,314)
Forfeited/cancelled   -   $-   $- 
Outstanding, July 31, 2025   524,999   $8.88   $14,185,473 
2017 Equity Plan and 2021 Equity Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended July 31, 2025, are presented in the tables below:

  

Predecessor                
Predecessor                
  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding as of April 30, 2025   -   $-    -   $- 
Granted   -   $-    -   $- 
Exercised   -   $-    -   $- 
Forfeited   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding as of June 6, 2025   -   $-    -   $- 
Exercisable as of June 6, 2025   -   $-    -   $- 

 

Successor                
Successor                
  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value

 
                 
Outstanding as of June 7, 2025   18,296   $83.19    5.2   $- 
Granted   2,700   $7.74    9.9   $52,056 
Exercised   -   $-    -   $- 
Forfeited   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding as of July 31, 2025   20,996   $73.49    5.6   $- 
Exercisable as of July 31, 2025   18,296   $83.19    5.0   $- 

 

 

CEA Industries Inc.

Notes to Condensed Consolidated Financial Statements

July 31, 2025

(in US Dollars except share numbers)

(Unaudited)

 

A summary of the nonvested non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended July 31, 2025, are presented in the tables below:

  

Predecessor                
Predecessor                
 

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant Date

Fair Value

 
                
Nonvested as of April 30, 2025   -   $-   $-   $- 
Granted   -   $-   $-   $- 
Vested   -   $-   $-   $- 
Forfeited   -   $-   $-   $- 
Expired   -   $-   $-   $- 
Nonvested as of June 6, 2025   -   $-    -   $- 

 

Successor                
Successor                
  

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic Value

  

Grant Date

Fair Value

 
                 
Nonvested as of June 7, 2025   -   $-   $-   $- 
Granted   2,700   $7.74   $52,056   $20,898 
Vested   -   $-   $-   $- 
Forfeited   -   $-   $-   $- 
Expired   -   $-   $-   $- 
Nonvested as of July 31, 2025   2,700   $7.74   $52,056   $20,898 
2017 And 2021 Equity Plan [Member] | Employee And Consultant [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Non-vested Non-qualified Stock Option Activity

A summary of the nonvested non-qualified stock options and incentive stock options granted to employees and consultants under the 2017 and 2021 Equity Plans during the three months ended July 31, 2025, are presented in the tables below:

  

Predecessor                
Predecessor                
 

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic

Value

  

Grant Date

Fair Value

 
                
Nonvested as of April 30, 2025   -   $-   $-   $- 
Granted   -   $-   $-   $- 
Vested   -   $-   $-   $- 
Forfeited   -   $-   $-   $- 
Expired   -   $-   $-   $- 
Nonvested as of June 6, 2025   -   $-    -   $- 

 

Successor                
Successor                
  

Number of

Options

  

Weighted

Average

Grant-Date

Fair Value

  

Aggregate

Intrinsic Value

  

Grant Date

Fair Value

 
                 
Nonvested as of June 7, 2025   -   $-   $-   $- 
Granted   2,700   $7.74   $52,056   $20,898 
Vested   -   $-   $-   $- 
Forfeited   -   $-   $-   $- 
Expired   -   $-   $-   $- 
Nonvested as of July 31, 2025   2,700   $7.74   $52,056   $20,898 
2017 And 2021 Equity Plan [Member] | Directors [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to directors under the 2017 and 2021 Equity Plans, during the three months ended July 31, 2025 (Successor), are presented in the tables below:

 

Predecessor                
 

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
Outstanding, April 30, 2025   -   $-    -   $- 
Granted   -   $-    -   $- 
Exercised   -   $-    -   $- 
Forfeited/Cancelled   -   $-    -   $- 
Expired   -   $-    -   $- 
Outstanding, June 6, 205   -   $-    -   $- 
Exercisable, June 6, 2025   -   $-    -   $- 

 

Successor                
  

Number of

Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term

  

Aggregate

Intrinsic

Value ($000)

 
Outstanding, June 7, 2025   4,760   $113.34    3.5   $- 
Granted   -   $-    -   $- 
Exercised   -   $-    -   $- 
Forfeited   -   $-    -   $- 
Expired   (1,111)  $52    -   $- 
Outstanding, July 31, 2025   3,649   $131.95    4.4   $- 
Exercisable, July 31, 2025   3,649   $131.95    4.4   $-